At CES, experts say transparency key to ensuring AI tools work as intended January 13, 2021 Auto Bot AI, AMA, Artificial Intelligence, FDA, Legal, News, Philips, Policy, regulation 0 AI tools increasingly occupy a regulatory gray area in healthcare. For clinicians to assess whether they are trustworthy, they need transparency on how they work, said panelists at CES.